S&P 500
5,940.54
-0.4%
-23.06
DJI
42,651.48
-0.3%
-140.59
NASDAQ
$19,149.64
-0.3%
-$65.83
Bitcoin
105,282.00
+0.5%
+488.84
AAPL
$207.74
-0.5%
-$1.04
AMZN
$203.49
-1.3%
-$2.67
GOOG
$168.24
+0.2%
+$0.37
META
$637.50
-0.5%
-$2.92
MSFT
$456.03
-0.6%
-$2.84
NVDA
$133.95
-1.2%
-$1.62
TSLA
$348.07
+1.7%
+$5.98
Biohaven (NYSE: BHVN)
$15.58
(-1.1%)
-$0.17
Price as of May 20, 2025, 12:09 p.m. ET
Biohaven Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Biohaven Company Info
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
News & Analysis
Featured Article
Why Biohaven Stock Dove by Nearly 20% on Thursday
Eric Volkman | May 15, 2025
Featured Article
Why BioHaven Stock Is Soaring Today
Johnny Rice | Apr 28, 2025
Why Biohaven Stock Plummeted by More Than 15% Today
Eric Volkman | Apr 25, 2025
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
Billy Duberstein | Apr 3, 2025
Why Biohaven Stock Triumphed on Tuesday
Eric Volkman | Feb 11, 2025
Why Biohaven Stock Is Crashing Today
Keith Speights | Jul 27, 2023
The clinical-stage biotech is going to remain in the clinical stage longer than it hoped.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.